Development of Assays for High-Throughput Drug Screening (R01)

The summary for the Development of Assays for High-Throughput Drug Screening (R01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Development of Assays for High-Throughput Drug Screening (R01): -Purpose. The overall goal of the Molecular Libraries Initiative, part of the NIH Roadmap for Medical Research, is to offer public sector researchers opportunities to screen small molecules with the high-throughput chemical screening (HTS) methods commonly used by the private sector to develop therapeutic agents. The purpose of this FOA is to support the development of innovative assays that may ultimately be adapted for automated screening. The assay should aim to identify new tools for basic research or promising new avenues for therapeutics development, especially in areas related to the missions of the participating institutes. -Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism. Applicants may request a project period of up to three years. Investigators who have already developed an assay to the point that it is ready for automated screening may want to consider applying for PAR-06-545 (R03). -Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality and costs of the applications received.
Federal Grant Title: Development of Assays for High-Throughput Drug Screening (R01)
Federal Agency Name: National Institutes of Health
Grant Categories: Education Health Food and Nutrition
Type of Opportunity: Discretionary
Funding Opportunity Number: PA-07-320
Type of Funding: Grant
CFDA Numbers: 93.24293.395
CFDA Descriptions: Mental Health Research Grants 93.395 Cancer Treatment Research
Current Application Deadline: No deadline provided
Original Application Deadline: Multiple Receipt Dates - See Link to Full Announce
Posted Date: Mar 19, 2007
Creation Date: Mar 19, 2007
Archive Date: Dec 05, 2008
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: 93.847 -- Diabetes, Endocrinology and Metabolism Research
Applicants Eligible for this Grant
Public and State controlled institutions of higher education City or township governments Others (see text field entitled "Additional Information on Eligibility" for clarification) Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Independent school districts State governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Special district governments Native American tribal governments (Federally recognized) County governments
Additional Information on Eligibility
Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
More Grants from the National Institutes of Health
Ethical Issues in Translational Science Research (R01 Clinical Trial Optional)
A Collaborative Network to Optimize Emergency Care of Older Adults with Alzheimers Disease...
Innovations to Foster Healthy Longevity in Low-Income Settings (R03 Clinical Trial Not All...
HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Instit...
National Dental Practice-Based Research Network Clinical Trial or Observational Study Plan... is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2020